Emily Sarver, NP
Family · Malvern, PANPI 1205448818
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 189 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Amgen at 29.7% of the total. Reporting peaked in 2022 at $936 and has fallen 70.9% since, to $272 in 2025. Among family clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 189 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$986
- Novartis$470
- AbbVie$462
- AstraZeneca$263
- UCB, Inc.$214
- Lilly USA, LLC$136
- plus $792 from 14 others
What the payments were for
- Food & beverage$3,315100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 46 | $986 |
| Novartis | 39 | $470 |
| AbbVie | 35 | $462 |
| AstraZeneca(2 entities) | 15 | $263 |
| UCB, Inc. | 9 | $214 |
| Lilly USA, LLC | 7 | $136 |
| Johnson & Johnson | 7 | $135 |
| Pfizer | 7 | $125 |
| Actelion Pharmaceuticals US, Inc. | 3 | $78 |
| GSK | 4 | $76 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $69 |
| ANI Pharmaceuticals, Inc. | 3 | $53 |
| Radius Health, Inc. | 2 | $49 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $41 |
| Vertex | 2 | $39 |
| Sanofi | 1 | $35 |
| Kyowa Kirin, Inc. | 1 | $29 |
| Aurinia Pharma U.S., Inc. | 1 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
How this compares
$3,323 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 55 | $1,869 |
| MethotrexateMethotrexate Sodium | 42 | $967 |
| Prednisone | 44 | $217 |
| Celecoxib | 11 | $183 |
| Duloxetine Hcl | 13 | $167 |
| Alendronate Sodium | 15 | $62 |
| Meloxicam | 12 | $14 |
Paid to pharmacies, not to this prescriber.
Other family in Malvern
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
- Patricia HabdasPittsburgh$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.